Gefshil Geftinib 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Gefshil Geftinib 250mg Tablet can be taken with or without food, but better to have it same time every day for better results.
Exports To: United States Of America | Philippines | Sri Lanka | Bangladesh | Saudi Arabia
Find products similar to Gefshil Geftinib 250mg Tablets
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
01-07-2017
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
Aug 2013
GST
27AADFE3806H1ZN
Import Export Code (IEC)
AADFE*****
Exports to
United States Of America | Philippines | Sri Lanka | Bangladesh | Saudi Arabia
Established in 2008 as an arm of an established domestic player, we are pioneering a Distributor, Trader, Importer, Exporter and Supplier of comprehensive range of Oncology Drugs, Anti Cancer Drugs, Life Saving Medicines, Orthopedic Injections, Nephrology Drugs, Gynecology Drugs, Urology Drugs, Vaccine Drugs and Pharmaceuticals Drugs. We offer pharmaceutical products that includes pharmaceutical drugs, oncology drugs, nephrology drugs, life saving medicine, super speciality medicine, orthopedic drugs, gynecology, virology, vaccines etc. We source all the products from the certified trusted vendors of the market, who makes there using premium ingredients & latest technology as per the international health & quality norms. We follow ethical business policies, which enable us to establish a congenial relationship with our clients and create a huge data base. For our accomplishment story, we are grateful to our Mr Shyamsunder Chandak whose continual backing and direction have been useful to us for attaining exponential development in the current market.
